Protocol TARC-ABPA

NACompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

September 21, 2017

Study Completion Date

September 21, 2017

Conditions
Allergic Broncho-Pulmonary Aspergillosis
Interventions
OTHER

Study of predictive factors

"Phase 1 : Inclusion of patients (V0) :~In the case of a participation agreement, data on age, profession, previous history, history of the disease and current treatments will be collected. Different tests will be performed at this visit.~Phase 2 : Determination of the baseline (V1) : Patients will be reviewed one month after V0 (V1). In the absence of exacerbation between V0 and V1, the examinations performed in routine practice will be used to determine the basic state of biological parameters of interest. During this visit, different tests will be performed.~Phase 3 : Quarterly monitoring of patients (V2-V9) : Patients will be followed every three months for 2 years (V2-V9)."

Trial Locations (2)

44093

Nantes University Hospital, Nantes

72037

CHU Le Mans, Le Mans

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT01710930 - Protocol TARC-ABPA | Biotech Hunter | Biotech Hunter